GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Plans » CVS Health Corp (NYSE:CVS) » Definitions » Altman Z-Score

CVS (CVS Health) Altman Z-Score : 2.07 (As of Dec. 12, 2024)


View and export this data going back to 1952. Start your Free Trial

What is CVS Health Altman Z-Score?

The Altman Z-Score is a model designed to predict the likelihood of a company going bankrupt within the next two years. Created by American finance professor Edward Altman in 1968, the model is specifically designed for publicly traded manufacturing companies with assets greater than $1 million.

Warning Sign:

Altman Z-score of 2.07 is in the grey area. This implies that the company is under some kind of financial stress. If it is below 1.8, the company may face bankruptcy risk.

CVS Health has a Altman Z-Score of 2.07, indicating it is in Grey Zones. This implies that CVS Health is in some kind of financial stress. If it is below 1.81, the company may face bankrupcy risk.

The zones of discrimination were as such:

When Altman Z-Score <= 1.8, it is in Distress Zones.
When Altman Z-Score >= 3, it is in Safe Zones.
When Altman Z-Score is between 1.8 and 3, it is in Grey Zones.

The historical rank and industry rank for CVS Health's Altman Z-Score or its related term are showing as below:

CVS' s Altman Z-Score Range Over the Past 10 Years
Min: 1.54   Med: 2.26   Max: 4.91
Current: 2.07

During the past 13 years, CVS Health's highest Altman Z-Score was 4.91. The lowest was 1.54. And the median was 2.26.


CVS Health Altman Z-Score Historical Data

The historical data trend for CVS Health's Altman Z-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CVS Health Altman Z-Score Chart

CVS Health Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Altman Z-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.97 1.95 2.25 2.32 2.26

CVS Health Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Altman Z-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.16 2.26 2.22 2.15 2.12

Competitive Comparison of CVS Health's Altman Z-Score

For the Healthcare Plans subindustry, CVS Health's Altman Z-Score, along with its competitors' market caps and Altman Z-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


CVS Health's Altman Z-Score Distribution in the Healthcare Plans Industry

For the Healthcare Plans industry and Healthcare sector, CVS Health's Altman Z-Score distribution charts can be found below:

* The bar in red indicates where CVS Health's Altman Z-Score falls into.



CVS Health Altman Z-Score Calculation

Altman Z-Score model is an accurate forecaster of failure up to two years prior to distress. It can be considered the assessment of the distress of industrial corporations.

CVS Health's Altman Z-Score for today is calculated with this formula:

Z=1.2*X1+1.4*X2+3.3*X3+0.6*X4+1.0*X5
=1.2*-0.0685+1.4*0.2458+3.3*0.0381+0.6*0.3673+1.0*1.4615
=2.07

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency. GuruFocus does not calculate Altman Z-Score when X4 or X5 value is 0.

Trailing Twelve Months (TTM) ended in Sep. 2024:
Total Assets was $252,427 Mil.
Total Current Assets was $67,343 Mil.
Total Current Liabilities was $84,627 Mil.
Retained Earnings was $62,038 Mil.
Pre-Tax Income was 105 + 2337 + 1580 + 2705 = $6,727 Mil.
Interest Expense was -752 + -732 + -716 + -690 = $-2,890 Mil.
Revenue was 95428 + 91234 + 88437 + 93813 = $368,912 Mil.
Market Cap (Today) was $65,135 Mil.
Total Liabilities was $177,321 Mil.

* Note that for stock reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data.

X1=Working Capital/Total Assets
=(Total Current Assets - Total Current Liabilities)/Total Assets
=(67343 - 84627)/252427
=-0.0685

X2=Retained Earnings/Total Assets
=62038/252427
=0.2458

X3=Earnings Before Interest and Taxes/Total Assets
=(Pre-Tax Income - Interest Expense)/Total Assets
=(6727 - -2890)/252427
=0.0381

X4=Market Value Equity/Book Value of Total Liabilities
=Market Cap/Total Liabilities
=65135.180/177321
=0.3673

X5=Revenue/Total Assets
=368912/252427
=1.4615

The zones of discrimination were as such:

Distress Zones - 1.81 < Grey Zones < 2.99 - Safe Zones

CVS Health has a Altman Z-Score of 2.07 indicating it is in Grey Zones.

Study by Altman found that companies that are in Distress Zone have more than 80% of chances of bankruptcy in two years.


CVS Health  (NYSE:CVS) Altman Z-Score Explanation

X1: The Working Capital/Total Assets (WC/TA) ratio is a measure of the net liquid assets of the firm relative to the total capitalization. Working capital is defined as the difference between current assets and current liabilities. Ordinarily, a firm experiencing consistent operating losses will have shrinking current assets in relation to total assets. Altman found this one proved to be the most valuable liquidity ratio comparing with the current ratio and the quick ratio. This is however the least significant of the five factors.

X2: Retained Earnings/Total Assets: the RE/TA ratio measures the leverage of a firm. Retained earnings is the account which reports the total amount of reinvested earnings and/or losses of a firm over its entire life. Those firms with high RE, relative to TA, have financed their assets through retention of profits and have not utilized as much debt.

X3, Earnings Before Interest and Taxes/Total Assets (EBIT/TA): This ratio is a measure of the true productivity of the firm's assets, independent of any tax or leverage factors. Since a firm's ultimate existence is based on the earning power of its assets, this ratio appears to be particularly appropriate for studies dealing with corporate failure. This ratio continually outperforms other profitability measures, including cash flow.

X4, Market Value of Equity/Book Value of Total Liabilities (MVE/TL): The measure shows how much the firm's assets can decline in value (measured by market value of equity plus debt) before the liabilities exceed the assets and the firm becomes insolvent.

X5, Revenue/Total Assets (S/TA): The capital-turnover ratio is a standard financial ratio illustrating the sales generating ability of the firm's assets.

Read more about Altman Z-Score and the original research.


Be Aware

Altman Z-Score does not apply to financial companies.


CVS Health Altman Z-Score Related Terms

Thank you for viewing the detailed overview of CVS Health's Altman Z-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


CVS Health Business Description

Address
One CVS Drive, Woonsocket, RI, USA, 02895
CVS Health offers a diverse set of healthcare services. Its roots are in its retail pharmacy operations, where it operates over 9,000 stores primarily in the us. CVS is also a large pharmacy benefit manager (acquired through Caremark), processing about 2 billion adjusted claims annually. It also operates a top-tier health insurer (acquired through Aetna) where it serves about 26 million medical members. The company's recent acquisition of Oak Street adds primary care services to the mix, which could have significant synergies with all its existing business lines.
Executives
Michael F Mahoney director BOSTON SCIENTIFIC CORPORATION, 300 BOSTON SCIENTIFIC WAY, MARLBOROUGH MA 01752-1234
Edward J Ludwig director C/O BECTON DICKERSON & CO, 1 BECTON DR, FRANKLIN LAKES NJ 07417
Prem S Shah officer: EVP and Co-President of Retail ONE CVS DRIVE, WOONSOCKET RI 02895
Thomas F. Cowhey officer: SVP, Interim CFO 310 SEVEN SPRINGS WAY, SUITE 500, BRENTWOOD TN 37027
J Scott Kirby director 233 S. WACKER DRIVE 11TH FL WHQLD, CHICAGO IL 60606
Brian A Kane officer: EVP/President, Aetna 500 W MAIN STREET, LOUISVILLE KY 40202
James David Clark officer: SVP, Cont & Chief Acct Officer ONE CVS DRIVE, WOONSOCKET RI 02760
Karen S Lynch officer: EVP & Pres, Aetna Bus Unit 151 FARMINGTON AVENUE, RW61, HARTFORD CT 06156
Samrat S. Khichi officer: EVP, CPO and General Counsel C/O CATALENT, INC., 14 SCHOOLHOUSE ROAD, SOMERSET NJ 08873
Thomas M Moriarty officer: EVP & General Counsel 100 PARSONS POND DRIVE, FRANKLIN LAKES NJ 07417
Jeffrey R. Balser director 3657 RICHLAND AVE., NASHVILLE TN 37205
Alan Lotvin officer: EVP, Transformation 55 NOD ROAD, AVON CT 06001
Daniel P Finke officer: EVP/Pres, Health Care Benefits ONE CVS DRIVE, WOONSOCKET RI 02895
Tilak Mandadi officer: EVP, Chief Technology Officer 3600 LAS VEGAS BLVD. SOUTH, LAS VEGAS NV 89109
Sreekanth K Chaguturu officer: EVP and Chief Medical Officer ONE CVS DRIVE, WOONSOCKET RI 02895